Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2023-08-01
2024-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multicenter Observational Cohort of Degenerative Spine Diseases in China(DSDC)
NCT05867732
MRI for Screening and Monitoring Scleroderma ILD
NCT05204355
FDG PET/MRI Evaluation of Facet Joint Pain
NCT02921490
Functioning Disturbance in Chronic Back Pain: Altered Muscle Metabolism
NCT01593839
To Investigate the Bone and Muscle Abnormalities in Patients With Chronic Kidney Disease With MRI
NCT04564924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pirffmann 2 grade
CXCL2/CXCL8
Detecte CXCL2/8 content in nucleus pulposus and peripheral blood of patients in each group
pirffmann 3 grade
CXCL2/CXCL8
Detecte CXCL2/8 content in nucleus pulposus and peripheral blood of patients in each group
pirffmann 4 grade
CXCL2/CXCL8
Detecte CXCL2/8 content in nucleus pulposus and peripheral blood of patients in each group
pirffmann 5 grade
CXCL2/CXCL8
Detecte CXCL2/8 content in nucleus pulposus and peripheral blood of patients in each group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CXCL2/CXCL8
Detecte CXCL2/8 content in nucleus pulposus and peripheral blood of patients in each group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhongda Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
pengfei, xue
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongda Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20220224016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.